## Background: Both antibodies to saccharomyces cerevisiae (asca) and carriage of two mutated nod2/card15 alleles are associated with ileal crohn's disease (cd) and complications requiring bowel surgery. we assessed the asca titer as a marker of cd clinical behavior. ## Methods: In a cross-sectio
Anti-Saccharomyces cerevisiae antibodies (ASCA) in Crohn's disease are associated with disease severity but not NOD2/CARD15 mutations
β Scribed by L. J. WALKER; M. C. ALDHOUS; H. E. DRUMMOND; B. R. K. SMITH; E. R. NIMMO; I. D. R. ARNOTT; J. SATSANGI
- Book ID
- 108698762
- Publisher
- John Wiley and Sons
- Year
- 2004
- Tongue
- English
- Weight
- 128 KB
- Volume
- 135
- Category
- Article
- ISSN
- 0009-9104
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
Background: NOD2 is involved in Crohn's disease (CD), but the role of NOD1 remains unclear. Anti-Saccharomyces cerevisiae antibodies (ASCA) are higher in CD patients and some of their relatives. Using family-based analyses we investigated the relationships between NOD2 mutations, NOD1 ΓΎ32656 variant
## Background: Pancreatic autoantibodies (pab) and goblet cell autoantibodies (gab) are specific for crohn's disease (cd) and ulcerative colitis (uc), but the sensitivity alone is low. conventional antibodies and carbohydrates (glycans) are associated with disease phenotype and may be of diagnostic